ABBOTT LABORATORIES — Director's Dealing 2023

Sep 7, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2023-09-01

Reporting Person: MCCOY JOHN A. JR. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15215	Direct
Common shares without par value	55	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$124.04	2031-02-18	Common Shares (13369)		Direct
Option (right to buy)	$117.58	2032-02-17	Common Shares (16632)		Direct
Option (right to buy)	$106.24	2033-02-16	Common Shares (12759)		Direct

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2023.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,456 on February 19, 2022, 4,456 on February 19, 2023, and 4,457 on February 19, 2024.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 5,544 on February 18, 2023, 5,544 on February 18, 2024 and 5,544 on February 18, 2025.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,253 on February 17, 2024, 4,253 on February 17, 2025, and 4,253 on February 17, 2026.